Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 9.52212913 |
2 | * sarcomere organization (GO:0045214) | 9.33836503 |
3 | myofibril assembly (GO:0030239) | 8.15129114 |
4 | muscle filament sliding (GO:0030049) | 8.07741014 |
5 | actin-myosin filament sliding (GO:0033275) | 8.07741014 |
6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.53978904 |
7 | cardiac muscle contraction (GO:0060048) | 7.19443446 |
8 | cardiac muscle cell development (GO:0055013) | 6.87183300 |
9 | actin-mediated cell contraction (GO:0070252) | 6.82326319 |
10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.70543088 |
11 | cardiac cell development (GO:0055006) | 6.47911121 |
12 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.32239762 |
13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.16976805 |
14 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.16183468 |
15 | * actomyosin structure organization (GO:0031032) | 6.15198530 |
16 | cardiac muscle hypertrophy (GO:0003300) | 6.12914628 |
17 | plasma membrane repair (GO:0001778) | 6.06937597 |
18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.00819174 |
19 | regulation of actin filament-based movement (GO:1903115) | 5.97318575 |
20 | regulation of relaxation of muscle (GO:1901077) | 5.94409414 |
21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.83359322 |
22 | adult heart development (GO:0007512) | 5.79099631 |
23 | striated muscle hypertrophy (GO:0014897) | 5.78711435 |
24 | tricarboxylic acid cycle (GO:0006099) | 5.76015223 |
25 | * muscle tissue morphogenesis (GO:0060415) | 5.72013269 |
26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.64535679 |
27 | heart process (GO:0003015) | 5.63320642 |
28 | heart contraction (GO:0060047) | 5.63320642 |
29 | striated muscle contraction (GO:0006941) | 5.54110139 |
30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.39253287 |
31 | regulation of sarcomere organization (GO:0060297) | 5.39218359 |
32 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.32155656 |
33 | regulation of skeletal muscle contraction (GO:0014819) | 5.28119293 |
34 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.26178377 |
35 | heart trabecula formation (GO:0060347) | 5.19435478 |
36 | actin filament-based movement (GO:0030048) | 5.16841173 |
37 | muscle hypertrophy (GO:0014896) | 5.12358838 |
38 | regulation of the force of heart contraction (GO:0002026) | 5.09828082 |
39 | regulation of cardioblast differentiation (GO:0051890) | 4.99068701 |
40 | regulation of striated muscle contraction (GO:0006942) | 4.88845220 |
41 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.80278864 |
42 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.75747367 |
43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.62446728 |
44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.55153266 |
45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.49159490 |
46 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.46817314 |
47 | cell communication involved in cardiac conduction (GO:0086065) | 4.41610921 |
48 | regulation of cell communication by electrical coupling (GO:0010649) | 4.40327825 |
49 | carnitine shuttle (GO:0006853) | 4.27889239 |
50 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.25244038 |
51 | ATP synthesis coupled proton transport (GO:0015986) | 4.23895939 |
52 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.23895939 |
53 | ventricular cardiac muscle cell development (GO:0055015) | 4.21900931 |
54 | cardiac muscle adaptation (GO:0014887) | 4.21107750 |
55 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.21107750 |
56 | muscle hypertrophy in response to stress (GO:0003299) | 4.21107750 |
57 | regulation of membrane repolarization (GO:0060306) | 4.11862664 |
58 | regulation of ATP catabolic process (GO:1903289) | 4.11177412 |
59 | regulation of ATPase activity (GO:0043462) | 4.11177412 |
60 | negative regulation of protein localization to cell surface (GO:2000009) | 4.04511105 |
61 | atrioventricular valve morphogenesis (GO:0003181) | 4.03890620 |
62 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.02692488 |
63 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.02535890 |
64 | cardiac ventricle formation (GO:0003211) | 3.99026122 |
65 | cell communication by electrical coupling (GO:0010644) | 3.97875723 |
66 | regulation of cardiac muscle contraction (GO:0055117) | 3.96366411 |
67 | striated muscle cell development (GO:0055002) | 3.94390990 |
68 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.91282254 |
69 | oxidative phosphorylation (GO:0006119) | 3.86776667 |
70 | regulation of heart rate (GO:0002027) | 3.84755810 |
71 | regulation of coenzyme metabolic process (GO:0051196) | 3.84406227 |
72 | regulation of cofactor metabolic process (GO:0051193) | 3.84406227 |
73 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.74695363 |
74 | respiratory electron transport chain (GO:0022904) | 3.73702478 |
75 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.71794700 |
76 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.71005942 |
77 | cardiac muscle cell action potential (GO:0086001) | 3.69808465 |
78 | muscle contraction (GO:0006936) | 3.66993596 |
79 | regulation of heart contraction (GO:0008016) | 3.66450526 |
80 | fatty acid transmembrane transport (GO:1902001) | 3.64608818 |
81 | electron transport chain (GO:0022900) | 3.62367533 |
82 | relaxation of cardiac muscle (GO:0055119) | 3.61856923 |
83 | atrial septum morphogenesis (GO:0060413) | 3.60038516 |
84 | negative regulation of potassium ion transport (GO:0043267) | 3.58170314 |
85 | muscle cell fate commitment (GO:0042693) | 3.58053496 |
86 | cardiac chamber formation (GO:0003207) | 3.57646639 |
87 | cell migration involved in heart development (GO:0060973) | 3.55280413 |
88 | regulation of muscle contraction (GO:0006937) | 3.49453943 |
89 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.45996396 |
90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.45626370 |
91 | muscle cell development (GO:0055001) | 3.42920452 |
92 | muscle system process (GO:0003012) | 3.42171769 |
93 | trabecula formation (GO:0060343) | 3.41665962 |
94 | endocardial cushion development (GO:0003197) | 3.41505007 |
95 | positive regulation of heart contraction (GO:0045823) | 3.34313126 |
96 | lymphangiogenesis (GO:0001946) | 3.32197352 |
97 | response to inactivity (GO:0014854) | 3.30740504 |
98 | wound healing, spreading of epidermal cells (GO:0035313) | 3.29692291 |
99 | cardiac conduction (GO:0061337) | 3.29122086 |
100 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.27404138 |
101 | striated muscle adaptation (GO:0014888) | 3.23999042 |
102 | gap junction assembly (GO:0016264) | 3.23682584 |
103 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.23381107 |
104 | response to muscle activity (GO:0014850) | 3.21702721 |
105 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.21224275 |
106 | cardiac muscle cell proliferation (GO:0060038) | 3.20212723 |
107 | outflow tract septum morphogenesis (GO:0003148) | 3.18893397 |
108 | cardiac muscle tissue development (GO:0048738) | 3.18884644 |
109 | regulation of tight junction assembly (GO:2000810) | 3.18852874 |
110 | positive regulation of action potential (GO:0045760) | 3.18253940 |
111 | desmosome organization (GO:0002934) | 3.17435392 |
112 | positive regulation of heart rate (GO:0010460) | 3.15982137 |
113 | skeletal muscle contraction (GO:0003009) | 3.15316260 |
114 | regulation of muscle system process (GO:0090257) | 3.13434757 |
115 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.07213275 |
116 | muscle adaptation (GO:0043500) | 3.05804044 |
117 | regulation of cardioblast proliferation (GO:0003264) | 3.04250497 |
118 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.04250497 |
119 | epithelial cell-cell adhesion (GO:0090136) | 3.03349971 |
120 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.02614218 |
121 | muscle cell cellular homeostasis (GO:0046716) | 2.99466140 |
122 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.98659043 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.05203795 |
2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.01695639 |
3 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.21646538 |
4 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.21646538 |
5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.17001385 |
6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.16304421 |
7 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.80253175 |
8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.78401498 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.59475372 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.52954006 |
11 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.94403248 |
12 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.75916675 |
13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.69311447 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52547311 |
15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.28547841 |
16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25771586 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24690647 |
18 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.20576715 |
19 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.12998270 |
20 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04965375 |
21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.00859813 |
22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.97492026 |
23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89824057 |
24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86947000 |
25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.79207218 |
26 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.72117780 |
27 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.64309969 |
28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64271306 |
29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61276096 |
30 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59002454 |
31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.54618455 |
32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54033268 |
33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48932210 |
34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46237659 |
35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45573328 |
36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.42384328 |
37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.42318540 |
38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41722700 |
39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41452810 |
40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41452810 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39691357 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39003396 |
43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.38581190 |
44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38570117 |
45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36403684 |
46 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34300578 |
47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.33478159 |
48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31913543 |
49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29768375 |
50 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29268740 |
51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29175345 |
52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29063376 |
53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25559948 |
54 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.22660206 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20256580 |
56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18298468 |
57 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18296476 |
58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17537183 |
59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17386862 |
60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16811937 |
61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16427147 |
62 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.15772503 |
63 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14903155 |
64 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.14392692 |
65 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14270812 |
66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13621116 |
67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12919854 |
68 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09790960 |
69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08126348 |
70 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07800520 |
71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07794154 |
72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07736423 |
73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07542955 |
74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05630469 |
75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05201643 |
76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04735999 |
77 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.04091137 |
78 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.04032459 |
79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02262869 |
80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01398398 |
81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00580058 |
82 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00437513 |
83 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00225291 |
84 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99182173 |
85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99114714 |
86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98700772 |
87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97368255 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96741833 |
89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96136476 |
90 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.95939958 |
91 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95229374 |
92 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94904316 |
93 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94904316 |
94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94784607 |
95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94178873 |
96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93518520 |
97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93000119 |
98 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92483543 |
99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91572718 |
100 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91521452 |
101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91259549 |
102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90625044 |
103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90345897 |
104 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90073727 |
105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88679181 |
106 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86242873 |
107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85906824 |
108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85906824 |
109 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84688717 |
110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.84667924 |
111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.84595716 |
112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84171089 |
113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84043963 |
114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83557468 |
115 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83416614 |
116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83111144 |
117 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82883218 |
118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82772985 |
119 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82418989 |
120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82156414 |
121 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81522871 |
122 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81334879 |
123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80512387 |
124 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.80221230 |
125 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.80101219 |
126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80071351 |
127 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80018407 |
128 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79866192 |
129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78896961 |
130 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.78043311 |
131 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77737297 |
132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77469372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 6.43967855 |
2 | MP0004084_abnormal_cardiac_muscle | 6.23242845 |
3 | MP0000751_myopathy | 4.76275175 |
4 | MP0004215_abnormal_myocardial_fiber | 4.48065088 |
5 | MP0003646_muscle_fatigue | 4.47388146 |
6 | MP0000749_muscle_degeneration | 4.27061150 |
7 | MP0004036_abnormal_muscle_relaxation | 4.21249241 |
8 | MP0005330_cardiomyopathy | 4.07466373 |
9 | MP0002972_abnormal_cardiac_muscle | 3.42091268 |
10 | MP0008775_abnormal_heart_ventricle | 3.17285474 |
11 | * MP0004087_abnormal_muscle_fiber | 3.14630167 |
12 | MP0003137_abnormal_impulse_conducting | 2.91421866 |
13 | MP0010630_abnormal_cardiac_muscle | 2.84145281 |
14 | MP0005385_cardiovascular_system_phenoty | 2.75181271 |
15 | MP0001544_abnormal_cardiovascular_syste | 2.75181271 |
16 | MP0000750_abnormal_muscle_regeneration | 2.72033008 |
17 | MP0005620_abnormal_muscle_contractility | 2.71420048 |
18 | MP0006138_congestive_heart_failure | 2.70084807 |
19 | MP0003828_pulmonary_edema | 2.33937118 |
20 | MP0004484_altered_response_of | 2.32978236 |
21 | MP0002269_muscular_atrophy | 2.30226097 |
22 | * MP0002106_abnormal_muscle_physiology | 2.29103438 |
23 | MP0003221_abnormal_cardiomyocyte_apopto | 2.28666467 |
24 | MP0004085_abnormal_heartbeat | 2.18653398 |
25 | MP0004510_myositis | 2.13319563 |
26 | MP0000747_muscle_weakness | 1.97922177 |
27 | MP0004130_abnormal_muscle_cell | 1.96773261 |
28 | MP0004145_abnormal_muscle_electrophysio | 1.93792098 |
29 | MP0000759_abnormal_skeletal_muscle | 1.88160665 |
30 | * MP0005369_muscle_phenotype | 1.88145243 |
31 | MP0002127_abnormal_cardiovascular_syste | 1.84496289 |
32 | MP0003950_abnormal_plasma_membrane | 1.83390299 |
33 | MP0004233_abnormal_muscle_weight | 1.69306090 |
34 | MP0003279_aneurysm | 1.53610380 |
35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.47280449 |
36 | MP0010368_abnormal_lymphatic_system | 1.39542388 |
37 | MP0005623_abnormal_meninges_morphology | 1.37680614 |
38 | MP0006036_abnormal_mitochondrial_physio | 1.37306842 |
39 | MP0003566_abnormal_cell_adhesion | 1.33213116 |
40 | MP0000266_abnormal_heart_morphology | 1.28803531 |
41 | MP0002234_abnormal_pharynx_morphology | 1.24573839 |
42 | MP0002332_abnormal_exercise_endurance | 1.12871990 |
43 | MP0010030_abnormal_orbit_morphology | 1.11959981 |
44 | MP0004272_abnormal_basement_membrane | 1.10037293 |
45 | MP0001661_extended_life_span | 1.09446588 |
46 | MP0003705_abnormal_hypodermis_morpholog | 1.04564225 |
47 | MP0000733_abnormal_muscle_development | 1.03902407 |
48 | MP0000343_altered_response_to | 1.01602745 |
49 | MP0005666_abnormal_adipose_tissue | 1.00170642 |
50 | MP0005670_abnormal_white_adipose | 0.99865769 |
51 | MP0002128_abnormal_blood_circulation | 0.98811402 |
52 | MP0000767_abnormal_smooth_muscle | 0.98729637 |
53 | MP0009384_cardiac_valve_regurgitation | 0.96297364 |
54 | MP0005165_increased_susceptibility_to | 0.96214280 |
55 | MP0005451_abnormal_body_composition | 0.95290765 |
56 | MP0008438_abnormal_cutaneous_collagen | 0.93441031 |
57 | MP0002108_abnormal_muscle_morphology | 0.89212684 |
58 | MP0006035_abnormal_mitochondrial_morpho | 0.86370842 |
59 | MP0009780_abnormal_chondrocyte_physiolo | 0.85338214 |
60 | MP0001879_abnormal_lymphatic_vessel | 0.79463428 |
61 | MP0000013_abnormal_adipose_tissue | 0.79295435 |
62 | MP0000230_abnormal_systemic_arterial | 0.77173151 |
63 | MP0001348_abnormal_lacrimal_gland | 0.73908612 |
64 | MP0005375_adipose_tissue_phenotype | 0.73460521 |
65 | MP0002925_abnormal_cardiovascular_devel | 0.69141067 |
66 | MP0003984_embryonic_growth_retardation | 0.66988374 |
67 | MP0002088_abnormal_embryonic_growth/wei | 0.66165220 |
68 | MP0005266_abnormal_metabolism | 0.65820305 |
69 | MP0001915_intracranial_hemorrhage | 0.60463224 |
70 | MP0005275_abnormal_skin_tensile | 0.58037901 |
71 | MP0003941_abnormal_skin_development | 0.57679314 |
72 | MP0004185_abnormal_adipocyte_glucose | 0.56891478 |
73 | MP0001614_abnormal_blood_vessel | 0.56876089 |
74 | MP0000003_abnormal_adipose_tissue | 0.56069758 |
75 | MP0002877_abnormal_melanocyte_morpholog | 0.53938423 |
76 | MP0001784_abnormal_fluid_regulation | 0.53520620 |
77 | MP0002933_joint_inflammation | 0.52723548 |
78 | MP0005503_abnormal_tendon_morphology | 0.51845244 |
79 | MP0003045_fibrosis | 0.51734587 |
80 | MP0000537_abnormal_urethra_morphology | 0.51160471 |
81 | MP0001542_abnormal_bone_strength | 0.49903340 |
82 | MP0003806_abnormal_nucleotide_metabolis | 0.49706515 |
83 | MP0005167_abnormal_blood-brain_barrier | 0.49585767 |
84 | MP0009250_abnormal_appendicular_skeleto | 0.49277376 |
85 | MP0003283_abnormal_digestive_organ | 0.47091182 |
86 | MP0002896_abnormal_bone_mineralization | 0.45181866 |
87 | MP0005197_abnormal_uvea_morphology | 0.43851981 |
88 | MP0002168_other_aberrant_phenotype | 0.43562492 |
89 | MP0005380_embryogenesis_phenotype | 0.43087394 |
90 | MP0001672_abnormal_embryogenesis/_devel | 0.43087394 |
91 | MP0002909_abnormal_adrenal_gland | 0.42744301 |
92 | MP0003091_abnormal_cell_migration | 0.41811926 |
93 | MP0000534_abnormal_ureter_morphology | 0.40336710 |
94 | MP0005595_abnormal_vascular_smooth | 0.38885040 |
95 | MP0008004_abnormal_stomach_pH | 0.38393211 |
96 | MP0005409_darkened_coat_color | 0.38263022 |
97 | MP0003385_abnormal_body_wall | 0.37833022 |
98 | MP0009840_abnormal_foam_cell | 0.37202608 |
99 | MP0001958_emphysema | 0.35895251 |
100 | MP0003300_gastrointestinal_ulcer | 0.35825701 |
101 | MP0010352_gastrointestinal_tract_polyps | 0.35323248 |
102 | MP0003948_abnormal_gas_homeostasis | 0.34102709 |
103 | MP0003122_maternal_imprinting | 0.33321638 |
104 | MP0005319_abnormal_enzyme/_coenzyme | 0.31967964 |
105 | MP0005187_abnormal_penis_morphology | 0.31629809 |
106 | MP0005388_respiratory_system_phenotype | 0.30481544 |
107 | MP0002133_abnormal_respiratory_system | 0.30481544 |
108 | MP0002971_abnormal_brown_adipose | 0.27684769 |
109 | MP0000249_abnormal_blood_vessel | 0.27311293 |
110 | MP0002295_abnormal_pulmonary_circulatio | 0.26518892 |
111 | MP0005023_abnormal_wound_healing | 0.26312399 |
112 | MP0003935_abnormal_craniofacial_develop | 0.25543651 |
113 | MP0001299_abnormal_eye_distance/ | 0.25333652 |
114 | MP0001727_abnormal_embryo_implantation | 0.24804123 |
115 | MP0003115_abnormal_respiratory_system | 0.24123774 |
116 | MP0001175_abnormal_lung_morphology | 0.22628556 |
117 | MP0001697_abnormal_embryo_size | 0.22406994 |
118 | MP0000428_abnormal_craniofacial_morphol | 0.21357071 |
119 | MP0000762_abnormal_tongue_morphology | 0.20939048 |
120 | MP0004043_abnormal_pH_regulation | 0.20306977 |
121 | MP0002078_abnormal_glucose_homeostasis | 0.20192711 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 8.11017416 |
2 | Ventricular tachycardia (HP:0004756) | 7.09644505 |
3 | Atrial fibrillation (HP:0005110) | 6.39636564 |
4 | Calf muscle hypertrophy (HP:0008981) | 6.16458789 |
5 | Primary atrial arrhythmia (HP:0001692) | 5.98459497 |
6 | Exercise-induced muscle cramps (HP:0003710) | 5.91104401 |
7 | Lipoatrophy (HP:0100578) | 5.82354067 |
8 | Muscle fiber splitting (HP:0003555) | 5.79796439 |
9 | Supraventricular tachycardia (HP:0004755) | 5.78207326 |
10 | Supraventricular arrhythmia (HP:0005115) | 5.68690343 |
11 | Abnormality of the calf musculature (HP:0001430) | 5.46692221 |
12 | Right ventricular cardiomyopathy (HP:0011663) | 5.45640002 |
13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.45242802 |
14 | Hyporeflexia of lower limbs (HP:0002600) | 5.42945898 |
15 | Exercise-induced myalgia (HP:0003738) | 5.28480011 |
16 | Subaortic stenosis (HP:0001682) | 5.17337931 |
17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.17337931 |
18 | Dilated cardiomyopathy (HP:0001644) | 4.68253958 |
19 | Syncope (HP:0001279) | 4.51005543 |
20 | EMG: myopathic abnormalities (HP:0003458) | 4.47295586 |
21 | Myoglobinuria (HP:0002913) | 4.35020185 |
22 | Bundle branch block (HP:0011710) | 4.34126494 |
23 | Palpitations (HP:0001962) | 4.25086444 |
24 | Prolonged QT interval (HP:0001657) | 4.06217854 |
25 | Ventricular arrhythmia (HP:0004308) | 4.04732756 |
26 | Increased connective tissue (HP:0009025) | 3.82617715 |
27 | Asymmetric septal hypertrophy (HP:0001670) | 3.70899518 |
28 | Heart block (HP:0012722) | 3.64742698 |
29 | Atrioventricular block (HP:0001678) | 3.58060038 |
30 | Abnormal atrioventricular conduction (HP:0005150) | 3.52075232 |
31 | Rhabdomyolysis (HP:0003201) | 3.45268295 |
32 | Ventricular fibrillation (HP:0001663) | 3.28467589 |
33 | Difficulty running (HP:0009046) | 3.20941907 |
34 | Distal lower limb muscle weakness (HP:0009053) | 3.10444276 |
35 | Popliteal pterygium (HP:0009756) | 3.01785069 |
36 | Difficulty climbing stairs (HP:0003551) | 2.98303877 |
37 | Left ventricular hypertrophy (HP:0001712) | 2.94508592 |
38 | Myotonia (HP:0002486) | 2.94487808 |
39 | Abnormality of the neuromuscular junction (HP:0003398) | 2.88807838 |
40 | Fatigable weakness (HP:0003473) | 2.88807838 |
41 | Aplasia of the musculature (HP:0100854) | 2.87515136 |
42 | Abnormal EKG (HP:0003115) | 2.87463048 |
43 | Bradycardia (HP:0001662) | 2.85021281 |
44 | Palmoplantar keratoderma (HP:0000982) | 2.81607542 |
45 | Protrusio acetabuli (HP:0003179) | 2.76694414 |
46 | Type 1 muscle fiber predominance (HP:0003803) | 2.75468957 |
47 | Arterial tortuosity (HP:0005116) | 2.72227517 |
48 | Type 2 muscle fiber atrophy (HP:0003554) | 2.71735939 |
49 | Neck muscle weakness (HP:0000467) | 2.66359877 |
50 | Premature rupture of membranes (HP:0001788) | 2.65516748 |
51 | Double outlet right ventricle (HP:0001719) | 2.64913400 |
52 | Congenital malformation of the right heart (HP:0011723) | 2.64913400 |
53 | Acute necrotizing encephalopathy (HP:0006965) | 2.64526585 |
54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.62906314 |
55 | Round ear (HP:0100830) | 2.56530576 |
56 | Hepatic necrosis (HP:0002605) | 2.54779545 |
57 | Vascular tortuosity (HP:0004948) | 2.52555086 |
58 | Aortic dissection (HP:0002647) | 2.51338351 |
59 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.49709145 |
60 | Muscle fiber atrophy (HP:0100295) | 2.43927191 |
61 | Ragged-red muscle fibers (HP:0003200) | 2.43370947 |
62 | Limb-girdle muscle atrophy (HP:0003797) | 2.42600920 |
63 | Abnormality of the tricuspid valve (HP:0001702) | 2.42193224 |
64 | Conjunctival hamartoma (HP:0100780) | 2.40615903 |
65 | Aortic aneurysm (HP:0004942) | 2.40349603 |
66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.38495183 |
67 | Areflexia of lower limbs (HP:0002522) | 2.37887985 |
68 | Abnormality of the foot musculature (HP:0001436) | 2.36684210 |
69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.35573617 |
70 | Lower limb amyotrophy (HP:0007210) | 2.33244139 |
71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32784069 |
72 | Muscle fiber inclusion bodies (HP:0100299) | 2.32126467 |
73 | Bulbar palsy (HP:0001283) | 2.30911858 |
74 | Generalized muscle weakness (HP:0003324) | 2.30619374 |
75 | Hip contracture (HP:0003273) | 2.28627252 |
76 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.24245035 |
77 | Gowers sign (HP:0003391) | 2.22167355 |
78 | Hepatocellular necrosis (HP:0001404) | 2.21922372 |
79 | Scapular winging (HP:0003691) | 2.21850150 |
80 | Hypoglycemic coma (HP:0001325) | 2.21284741 |
81 | Foot dorsiflexor weakness (HP:0009027) | 2.19404410 |
82 | Acute encephalopathy (HP:0006846) | 2.17538534 |
83 | Mitochondrial inheritance (HP:0001427) | 2.17068071 |
84 | Malignant hyperthermia (HP:0002047) | 2.15931259 |
85 | Progressive macrocephaly (HP:0004481) | 2.14287536 |
86 | Ketoacidosis (HP:0001993) | 2.13971699 |
87 | Distal lower limb amyotrophy (HP:0008944) | 2.13895669 |
88 | Hypoplastic heart (HP:0001961) | 2.13048557 |
89 | Sudden cardiac death (HP:0001645) | 2.11998068 |
90 | Easy fatigability (HP:0003388) | 2.11036704 |
91 | Congestive heart failure (HP:0001635) | 2.10751870 |
92 | Testicular atrophy (HP:0000029) | 2.09967022 |
93 | EMG: neuropathic changes (HP:0003445) | 2.09781157 |
94 | Exercise intolerance (HP:0003546) | 2.09284742 |
95 | Rimmed vacuoles (HP:0003805) | 2.08380428 |
96 | Distal arthrogryposis (HP:0005684) | 2.07493726 |
97 | Increased CSF lactate (HP:0002490) | 2.07006195 |
98 | Pheochromocytoma (HP:0002666) | 2.06582315 |
99 | Limited hip movement (HP:0008800) | 2.05032265 |
100 | Hypoplastic left heart (HP:0004383) | 2.04209941 |
101 | Abnormality of placental membranes (HP:0011409) | 2.03967196 |
102 | Amniotic constriction ring (HP:0009775) | 2.03967196 |
103 | Cerebral aneurysm (HP:0004944) | 2.03619931 |
104 | Thin ribs (HP:0000883) | 2.01894499 |
105 | Diaphragmatic weakness (HP:0009113) | 2.01270964 |
106 | Neoplasm of the adrenal gland (HP:0100631) | 2.00359965 |
107 | Muscular dystrophy (HP:0003560) | 2.00028950 |
108 | Muscle stiffness (HP:0003552) | 1.98817279 |
109 | Fetal akinesia sequence (HP:0001989) | 1.98631735 |
110 | Cerebral edema (HP:0002181) | 1.97924854 |
111 | Ulnar deviation of the wrist (HP:0003049) | 1.94545003 |
112 | Spinal rigidity (HP:0003306) | 1.93263052 |
113 | Increased muscle lipid content (HP:0009058) | 1.91292003 |
114 | Respiratory failure (HP:0002878) | 1.88996627 |
115 | Patent foramen ovale (HP:0001655) | 1.86723524 |
116 | Wrist flexion contracture (HP:0001239) | 1.85581803 |
117 | Nemaline bodies (HP:0003798) | 1.84847045 |
118 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84231853 |
119 | Neuroendocrine neoplasm (HP:0100634) | 1.83372871 |
120 | Pterygium (HP:0001059) | 1.81180144 |
121 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80954728 |
122 | Hamartoma of the eye (HP:0010568) | 1.80694777 |
123 | Aneurysm (HP:0002617) | 1.80088368 |
124 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.79696782 |
125 | Dicarboxylic aciduria (HP:0003215) | 1.79696782 |
126 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79689646 |
127 | Abnormality of glycolysis (HP:0004366) | 1.77246557 |
128 | Increased serum pyruvate (HP:0003542) | 1.77246557 |
129 | Pulmonary artery stenosis (HP:0004415) | 1.76060017 |
130 | Waddling gait (HP:0002515) | 1.74413146 |
131 | Lactic acidosis (HP:0003128) | 1.72691522 |
132 | Hypoplastic ischia (HP:0003175) | 1.71962706 |
133 | Increased intramyocellular lipid droplets (HP:0012240) | 1.70367339 |
134 | Facial diplegia (HP:0001349) | 1.69256455 |
135 | Weak cry (HP:0001612) | 1.68984249 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.51962753 |
2 | OBSCN | 5.48791273 |
3 | MYLK | 4.77368198 |
4 | LMTK2 | 3.42697930 |
5 | PKN2 | 3.42390536 |
6 | DMPK | 3.16601213 |
7 | PHKG2 | 2.95870590 |
8 | PHKG1 | 2.95870590 |
9 | MUSK | 2.84822832 |
10 | PDK4 | 2.71454735 |
11 | PDK3 | 2.71454735 |
12 | PIK3CA | 2.70588569 |
13 | TRIB3 | 2.59968970 |
14 | STK24 | 2.57005505 |
15 | STK38L | 1.94380691 |
16 | NEK1 | 1.89244342 |
17 | ZAK | 1.86941052 |
18 | TIE1 | 1.81038059 |
19 | PAK3 | 1.73186203 |
20 | BCKDK | 1.65980175 |
21 | ILK | 1.63237172 |
22 | CDC42BPA | 1.53009651 |
23 | PDK2 | 1.52775925 |
24 | ROCK1 | 1.36210588 |
25 | TRPM7 | 1.31419152 |
26 | DAPK3 | 1.27102660 |
27 | CAMK2D | 1.23887123 |
28 | PRKD1 | 1.23692229 |
29 | FLT3 | 1.17419571 |
30 | PINK1 | 1.13855119 |
31 | STK4 | 1.07402823 |
32 | PDGFRA | 1.06978965 |
33 | RIPK1 | 1.00493139 |
34 | GRK7 | 1.00090532 |
35 | PTK2B | 0.95975587 |
36 | MAP3K12 | 0.95843704 |
37 | WNK4 | 0.94328888 |
38 | MAP3K5 | 0.92358755 |
39 | LIMK1 | 0.91786302 |
40 | MAPKAPK3 | 0.89795915 |
41 | ERBB4 | 0.88581204 |
42 | ROCK2 | 0.88009597 |
43 | MAP3K7 | 0.84000159 |
44 | MAP3K6 | 0.82010993 |
45 | MARK1 | 0.76768475 |
46 | MET | 0.75604542 |
47 | PKN1 | 0.70596486 |
48 | MAPK12 | 0.69571849 |
49 | NTRK1 | 0.69101455 |
50 | LATS1 | 0.68001018 |
51 | PRKAA2 | 0.66903704 |
52 | PRKAA1 | 0.65127150 |
53 | STK38 | 0.64476821 |
54 | EPHB2 | 0.63971615 |
55 | CAMK2B | 0.62551882 |
56 | KDR | 0.61959502 |
57 | MAPK7 | 0.61893406 |
58 | CAMK1 | 0.58483102 |
59 | CAMK2A | 0.57528839 |
60 | WNK1 | 0.57315317 |
61 | MAP3K3 | 0.56606763 |
62 | PAK2 | 0.54209666 |
63 | TGFBR2 | 0.54175281 |
64 | LRRK2 | 0.53310177 |
65 | RPS6KL1 | 0.53309520 |
66 | RPS6KC1 | 0.53309520 |
67 | NEK9 | 0.53183645 |
68 | INSRR | 0.52287043 |
69 | LATS2 | 0.51342761 |
70 | CAMK4 | 0.50877288 |
71 | PAK6 | 0.50444312 |
72 | MAP3K10 | 0.49409691 |
73 | PTK6 | 0.49136211 |
74 | AKT2 | 0.47008904 |
75 | MAP2K3 | 0.46407878 |
76 | PRKACB | 0.44741256 |
77 | RPS6KA6 | 0.44266006 |
78 | MOS | 0.44086956 |
79 | PRKCE | 0.41514266 |
80 | MAPK4 | 0.39939310 |
81 | ZAP70 | 0.38247162 |
82 | FER | 0.37536431 |
83 | TESK1 | 0.37361728 |
84 | PRKG2 | 0.36672291 |
85 | CAMK2G | 0.35200807 |
86 | STK3 | 0.34996926 |
87 | EPHA3 | 0.33003411 |
88 | MAP2K1 | 0.32923074 |
89 | NME2 | 0.32280597 |
90 | ABL2 | 0.30522198 |
91 | PRKACA | 0.29983902 |
92 | PRKD3 | 0.29887053 |
93 | SCYL2 | 0.29660594 |
94 | MTOR | 0.29110327 |
95 | DDR2 | 0.28725025 |
96 | STK39 | 0.28584272 |
97 | EPHB1 | 0.27096974 |
98 | CDK8 | 0.26252022 |
99 | SGK3 | 0.25995685 |
100 | PRKACG | 0.25783870 |
101 | IRAK3 | 0.25609764 |
102 | PRKCH | 0.25569751 |
103 | MAP3K13 | 0.24942121 |
104 | PTK2 | 0.24034239 |
105 | PRKD2 | 0.23500698 |
106 | PRKG1 | 0.23074132 |
107 | GSK3A | 0.22020633 |
108 | FGFR1 | 0.21250213 |
109 | ITK | 0.21014801 |
110 | PDGFRB | 0.19803268 |
111 | PIM2 | 0.18311832 |
112 | RPS6KB2 | 0.17960136 |
113 | PAK4 | 0.17596246 |
114 | ARAF | 0.17210050 |
115 | PIK3CG | 0.16654634 |
116 | MAPKAPK2 | 0.16123118 |
117 | RPS6KA1 | 0.15461726 |
118 | ICK | 0.15425418 |
119 | NUAK1 | 0.13420735 |
120 | PDPK1 | 0.12655322 |
121 | TGFBR1 | 0.11682436 |
122 | RPS6KA2 | 0.11640370 |
123 | RET | 0.11420947 |
124 | EPHA2 | 0.10767611 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.62805785 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.91076943 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.46205439 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.46036843 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.88621424 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.34811780 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19363204 |
8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.98045484 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87784547 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.65379890 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.43730401 |
12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.41110388 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39497964 |
14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.15856223 |
15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.15082376 |
16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.94333815 |
17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.91025715 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79024464 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72164370 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57590095 |
21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51026438 |
22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41177856 |
23 | Focal adhesion_Homo sapiens_hsa04510 | 1.26227434 |
24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25315481 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21946801 |
26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21482201 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21051786 |
28 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11255907 |
29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07428777 |
30 | Tight junction_Homo sapiens_hsa04530 | 1.04261939 |
31 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.00771445 |
32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98521511 |
33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98431584 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93134113 |
35 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92739907 |
36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90737622 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89394825 |
38 | Adherens junction_Homo sapiens_hsa04520 | 0.87598480 |
39 | Insulin resistance_Homo sapiens_hsa04931 | 0.87287472 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85356730 |
41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83535406 |
42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79545840 |
43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76736603 |
44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75815117 |
45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75434484 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71482079 |
47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67813947 |
48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66898291 |
49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66407963 |
50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65744794 |
51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63846235 |
52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61527547 |
53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61020938 |
54 | Lysine degradation_Homo sapiens_hsa00310 | 0.59971372 |
55 | Prion diseases_Homo sapiens_hsa05020 | 0.59519695 |
56 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58517738 |
57 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57238922 |
58 | Amoebiasis_Homo sapiens_hsa05146 | 0.56929227 |
59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56832627 |
60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54285101 |
61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53958998 |
62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51079795 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50497134 |
64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50400838 |
65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47171236 |
66 | Bladder cancer_Homo sapiens_hsa05219 | 0.45800234 |
67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45278485 |
68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45075218 |
69 | Bile secretion_Homo sapiens_hsa04976 | 0.44417966 |
70 | Axon guidance_Homo sapiens_hsa04360 | 0.44261280 |
71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40949840 |
72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39842827 |
73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39489283 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34231769 |
75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33818888 |
76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33161860 |
77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32663804 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32400795 |
79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29743218 |
80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29041425 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28222742 |
82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27729372 |
83 | Malaria_Homo sapiens_hsa05144 | 0.27142839 |
84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26626036 |
85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25772925 |
86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24853147 |
87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24727711 |
88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24363349 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.23061358 |
90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21509115 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21316666 |
92 | Renin secretion_Homo sapiens_hsa04924 | 0.20947505 |
93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20400740 |
94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19970869 |
95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19245070 |
96 | Peroxisome_Homo sapiens_hsa04146 | 0.19219405 |
97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19123278 |
98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18955015 |
99 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.16395925 |
100 | Insulin secretion_Homo sapiens_hsa04911 | 0.15840845 |
101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.12757783 |
102 | Gap junction_Homo sapiens_hsa04540 | 0.12296338 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.11667049 |
104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.10606440 |
105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09691892 |
106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.09691057 |
107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09326977 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09231092 |
109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08838048 |
110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.08429688 |
111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.08335657 |
112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07737399 |
113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07201634 |
114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.05431107 |
115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.05425802 |
116 | Melanoma_Homo sapiens_hsa05218 | 0.05323932 |
117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.05316840 |
118 | Melanogenesis_Homo sapiens_hsa04916 | 0.04888635 |
119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.04227729 |
120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.03657435 |
121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.01834069 |
122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.01299167 |